Chad Winters - 11 Mar 2024 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
VP, Chief Accounting Officer
Signature
/s/ Luis Cantarero
Issuer symbol
WST
Transactions as of
11 Mar 2024
Net transactions value
-$175,512
Form type
4
Filing time
12 Mar 2024, 11:46:16 UTC
Previous filing
22 Feb 2024
Next filing
20 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WST Common Stock Options Exercise $116,924 +675 +47% $173.22 2,124 11 Mar 2024 Direct F1
transaction WST Common Stock Sale $292,436 -815 -38% $358.82 1,309 11 Mar 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Stock Options (Right to Buy) Options Exercise $0 -675 -43% $0.000000 896 11 Mar 2024 Stock Options (Right to Buy) 675 $173.22 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 2021 PSUs (PP20) award vesting net of taxes withheld.